GME
GameStop Corp.
GME's fundamentals are strong: its operating margin rose 11 points to 14% and it turned 19% of its revenue into free cash flow, though revenue fell 7.7%. At 17x earnings, it's trading less than half its usual 44x. Analysts expect earnings to fall sharply.
UCAR
U Power Limited
There isn't enough reported data to score UCAR yet.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
UCAR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
UCAR's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME's PE is in its cheap range at 17x. Analysts expect earnings to fall, which would put today's price at 38x next year's earnings, in its fair range.
UCAR PE Valuation
UCAR has no meaningful PE right now: it lost money over the past year.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
UCAR Forward outlook
There aren't enough analyst estimates for UCAR to show an outlook.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over UCAR in the latest year-over-year earnings comparison.
UCAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$728.48 | -$273.46 |
| Q4 2025 | -$451.71 | +$52.23 |
UCAR is still losing money, but far less than before: $728.48 per share over the past year, against $2,761.31 at its worst in late 2022.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME has the edge over UCAR on profitability, with a higher operating margin.
UCAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.2M | -17% |
| Q4 2025 | $3.5M | -25% |
| Q2 2025 | $2.7M | +34% |
| Q4 2024 | $4.7M | +74% |
| Q2 2024 | $2M | +596% |
| Q4 2023 | $2.7M | +129% |
| Q4 2022 | $1.2M | +95% |
| Q4 2021 | $601K | +447% |
UCAR has the edge over GME in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -542% | -342 points |
| Q4 2025 | -174% | -83 points |
| Q2 2025 | -98% | +984 points |
| Q4 2024 | -102% | +620 points |
| Q2 2024 | -200% | +361 points |
| Q4 2023 | -92% | +470 points |
| Q2 2023 | -1083% | +11 points |
| Q4 2022 | -722% | +372 points |
UCAR's operating margin was −542% last quarter, down 342 points from the same quarter a year ago.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME generated $688M in free cash flow over the past year, up 43% from the year before.
UCAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$3.1M | +$3.9M |
| Q4 2021 | -$7M | -$5.2M |
| Q2 2021 | -$7M | -$5.2M |
UCAR and GME do not have enough comparable growth data to identify a winner.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has the edge over UCAR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
UCAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +10% | +2.3K shares |
| 1 year | +59% | +9.3K shares |
UCAR has 25,148 diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $36M |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
GME Net Leverage
UCAR Net Leverage
UCAR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
UCAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.5 | Oversold |
| Stochastic | 3.2 | Oversold |
UCAR's weekly RSI is 21 (oversold) and its Stochastic is 3 (oversold).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
UCAR PE vs Consumer Cyclical Sector
UCAR has no meaningful PE right now: it lost money over the past year.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has stronger trend alignment. GME is above 5 of 5 weekly averages versus UCAR above 0 of 4.
UCAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 17% below |
| 20 week MA | $10.6 | 72% below |
| 50 week MA | $101.2 | 97% below |
| 100 week MA | $366.9 | 99% below |
UCAR is in a downtrend: it's below all four of its weekly moving averages, and 99% below its 100-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over UCAR on returns for 2026, with the stronger performance.
UCAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $156,600.0 | $3,670.0 | -98% |
| 2024 | $3,670.0 | $1,326.0 | -64% |
| 2025 | $1,326.0 | $338.0 | -75% |
| 2026 YTD | $338.0 | $2.93 | -99% |
UCAR has finished every year since 2023 lower, and it's down 99% so far in 2026.